These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 2438343

  • 1. Characterization of five Shigella flexneri variant Y-specific monoclonal antibodies using defined saccharides and glycoconjugate antigens.
    Carlin NI, Bundle DR, Lindberg AA.
    J Immunol; 1987 Jun 15; 138(12):4419-27. PubMed ID: 2438343
    [Abstract] [Full Text] [Related]

  • 2. Characterization of Shigella flexneri-specific murine monoclonal antibodies by chemically defined glycoconjugates.
    Carlin NI, Gidney MA, Lindberg AA, Bundle DR.
    J Immunol; 1986 Oct 01; 137(7):2361-6. PubMed ID: 3531329
    [Abstract] [Full Text] [Related]

  • 3. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics.
    Phalipon A, Folgori A, Arondel J, Sgaramella G, Fortugno P, Cortese R, Sansonetti PJ, Felici F.
    Eur J Immunol; 1997 Oct 01; 27(10):2620-5. PubMed ID: 9368618
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains.
    Carlin NI, Lindberg AA.
    Infect Immun; 1987 Jun 01; 55(6):1412-20. PubMed ID: 2437036
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibodies demonstrate multiple epitopes on the O antigens of Salmonella typhimurium LPS.
    Elkins K, Metcalf ES.
    J Immunol; 1984 Oct 01; 133(4):2255-60. PubMed ID: 6206158
    [Abstract] [Full Text] [Related]

  • 6. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
    Phalipon A, Tanguy M, Grandjean C, Guerreiro C, Bélot F, Cohen D, Sansonetti PJ, Mulard LA.
    J Immunol; 2009 Feb 15; 182(4):2241-7. PubMed ID: 19201878
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE, Michalek SM, Briles DE, Jirillo E, McGhee JR.
    J Immunol; 1984 Aug 15; 133(2):950-7. PubMed ID: 6203984
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monoclonal antibodies specific for O-antigenic polysaccharides of Shigella flexneri: clones binding to II, II:3,4, and 7,8 epitopes.
    Carlin NI, Lindberg AA.
    J Clin Microbiol; 1983 Nov 15; 18(5):1183-9. PubMed ID: 6196376
    [Abstract] [Full Text] [Related]

  • 11. Binding specificity for four monoclonal antibodies recognizing terminal Gal alpha 1-->4Gal residues in Haemophilus influenzae lipopolysaccharide.
    Borrelli S, Altmann K, Jansson PE, Lindberg AA.
    Microb Pathog; 1995 Sep 15; 19(3):139-57. PubMed ID: 8559043
    [Abstract] [Full Text] [Related]

  • 12. Epitope mapping of six monoclonal antibodies recognizing the Shigella dysenteriae type 1 O-antigenic repeating unit expressed in Escherichia coli K-12.
    Fält IC, Lindberg AA.
    Microb Pathog; 1994 Jan 15; 16(1):27-41. PubMed ID: 7520112
    [Abstract] [Full Text] [Related]

  • 13. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
    Coughlin RT, Bogard WC.
    J Immunol; 1987 Jul 15; 139(2):557-61. PubMed ID: 3298431
    [Abstract] [Full Text] [Related]

  • 14. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV, Turbyfill KR.
    Vaccine; 2006 Mar 20; 24(13):2290-301. PubMed ID: 16364513
    [Abstract] [Full Text] [Related]

  • 15. Preliminary crystallographic analysis of a Fab specific for the O-antigen of Shigella flexneri cell surface lipopolysaccharide with and without bound saccharides.
    Vyas MN, Vyas NK, Meikle PJ, Sinnott B, Pinto BM, Bundle DR, Quiocho FA.
    J Mol Biol; 1993 May 05; 231(1):133-6. PubMed ID: 8496958
    [Abstract] [Full Text] [Related]

  • 16. Production and characterization of monoclonal antibodies with diagnostic potential against Shigella flexneri.
    Islam MS, Stimson WH.
    J Clin Lab Immunol; 1989 Aug 05; 29(4):199-206. PubMed ID: 2700207
    [Abstract] [Full Text] [Related]

  • 17. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV, Roberts F, Verma NK.
    FEMS Immunol Med Microbiol; 2006 Apr 05; 46(3):444-51. PubMed ID: 16553820
    [Abstract] [Full Text] [Related]

  • 18. Production and partial characterization of monoclonal antibodies to Pasteurella haemolytica A1 capsular polysaccharide and lipopolysaccharide.
    Penaredondo MV, Maheswaran SK, Whiteley LO, Ames TR, Leininger JR.
    Am J Vet Res; 1988 Nov 05; 49(11):1962-8. PubMed ID: 2470277
    [Abstract] [Full Text] [Related]

  • 19. Characterization of monoclonal antibodies with specificity for the core oligosaccharide of Shigella lipopolysaccharide.
    Rahman SR, Stimson WH.
    Hybridoma; 2001 Apr 05; 20(2):85-90. PubMed ID: 11394534
    [Abstract] [Full Text] [Related]

  • 20. Structural characterization and serological specificities of lipopolysaccharides from Salmonella enterica serovar Gallinarum biovar Pullorum standard, intermediate and variant antigenic type strains.
    Brooks BW, Perry MB, Lutze-Wallace CL, Maclean LL.
    Vet Microbiol; 2008 Jan 25; 126(4):334-44. PubMed ID: 17855026
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.